Categories

Above the Fold

POLICY: Ignorance is not bliss

Young punk Kate Steadman has a very interesting post about the uninsured over at Health Policy

The current display of ignorance was on the subject of being uninsured. The woman I talked with didn’t really understand what it meant to be uninsured until her housekeeper had a health problem and couldn’t get seen by a doctor.

Look down in the comments for a combination of ignorance and desperation, and you’ll see why this will end up the political topic of the next two decades, as I said in my Spot-on piece last week.

And a big Hat-tip to Derek Lowe who’s doing Grand Rounds this week.

POLICY: Another balanced debate–what did you expect from the WSJ editorial pages?

So in this online "debate" about consumer health care called Consumer Choice: Can It Cure The Nation’s Health-Care Ills? the WSJ editorial page shows its lack of bias by having two HSA advocates, and one very tired liberal debunking them.  And Reischauer obviously couldn’t type as fast as the other two.

And no one mentioned the 80/20 rule, nor the RAND experiment that showed that needed care was forgone as often as un-needed care. And despite the fact that the two HSA loonies claim that we do not apparently ration by price, we have a huge rate of bankruptcies caused by medical bills, and huge numbers of the poor are unable to afford reccomended care or have trouble paying for care compared to poor people in other countries. But why bother using actual data published in peer reviewed journals when you can wax poetic telling lies about South Africa while ignoring what’s going on in Singapore. But it’s a "debate" so why sweat the small stuff?

TCHB: Jobs and requested people

I’m getting an increasing number of people calling me looking for senior and not so senior health care consulting, strategy and marketing types. Not that I’ve figured out how to get in the middle of this or make any money out of it yet, but if you are looking and want to send me a little synopsis, go ahead. (I will of course treat any emails with the fullest confidentiality). Extra points for senior consultants who want to head to the East Coast, and health plan marketing types interested in the south and Texas.

Let me know….

QUALITY: We spend how much on the NIH and how much on AHQR?

This is far, far too true.

Spending less money on better drugs and more on getting existing therapies to patients would save more lives. That’s the conclusion of a study published by a Virginia Commonwealth University family medicine and public health physician."For every dollar Congress gives the National Institutes of Health to develop blockbuster treatments, it spends only one penny to ensure that Americans actually receive them," said Steven Woolf, professor and director of research in VCU’s Department of Family Medicine and a member of the National Academy of Sciences’ Institute of Medicine. "This reflects, in part, a misperception that the improved drugs, procedures and the like will improve health outcomes, and that does not happen," he said.To illustrate, Woolf used a theoretical disease that claims 100,000 lives a year. If a drug is available that reduces the mortality rate from that disease by 20 percent, it has the potential to save 20,000 lives each year, he said. But if only 60 percent of eligible patients receive the drug, only 12,000 deaths will be averted. So closing the gap in care by making it available to 100 percent of eligible patients would save 8,000 additional lives, Woolf said.But to save the same number of lives by making a better drug and without closing the gap in care, i.e., delivering the better drug to only 60 percent of eligible patients, the drug’s lowering of mortality would have to be increased from 20 percent to 33 percent, he noted. Calling this the "break-even point," Woolf said that is an unrealistic goal for many treatments. In fact, the study showed that the billions invested in statins and anti-clotting drugs failed to reach the break-even point.

And we know that this is not just theoretical.

THCB: Wussies–Tough? Try not drinking for a month

Apparently it’s to difficult to give up drinking for a month.  As many of my friends will tell you I drink my fair share of alcohol, but I’ve managed it quite a few times. The LA Times reports how difficult it was for a group of fit people to give it up for a month

For moderate social drinkers, hopping on the wagon for a month shouldn’t have been that daunting of a task. Not just any moderate social drinkers, but a handful of men and women who are exceptionally fit, as in training-for-a-marathon fit. These are people used to discipline and healthy lifestyles, people who can get through a rigorous boot camp class without hurling. Yet some found that wagon trip much more uncomfortable than they thought, and didn’t even last a month. Some didn’t even make it a week.

Well they must have been a particularly weak-willed bunch. This year for two separate months (March and October) I’ve given up drinking and meat, and sugar and carbs) in order to lose weight. Of the four food groups I quit — yes I basically ate fish and vegetables — sugar is by far the hardest to give up.  Thank god for Splenda. Booze is easy to do for a month, and I’m always happy to fall off the wagon at the end of it. Whether the odd month every few years is going to help my well-exercised liver in the long run, I doubt.

TECH: Can doctors ever learn to love the EMR?

This was my editorial at FierceHealthcare on Friday

This week I heard a very bitter physician complaining that using an electronic
medical record got between him and caring for his patients, and imposed
secretarial tasks on him. Then on Tuesday we got perhaps the most negative news
yet about a problematic CPOE installation at Childrens’ Hospital in Pittsburgh,
where after its introduction patient mortality increased. There was also news
about an emergency department in Arizona pulling the plug on its EMR.

Whatever the real reasons behind the data, it’s clear that simply installing
an EMR or CPOE system did not have the desired impact on patient safety. My
cursory assessment is that electronic records are vital in improving the
healthcare delivered to patients, particularly those with chronic illnesses,
over the continuum of care. But it’s clear that when they’re introduced to ICUs
or ED, where speed is the key and care processes are not well defined, things
may not be so successful. A real examination of the process absent the
technology, and a massive commitment from vendors to improve the human-computer
interface, is quickly needed before the movement toward CPOE and EMR is stopped
by these kinds of stories. After all, it’s easy for a hospitals or physician
groups to decide instead to do nothing.

Well, some people were reading. Kelly Clark a physician from Boston, recently relocated to
Louisville, wasn’t too impressed. She wrote to me:

Any time you want to hear a physician complain about using
CPOE/EMR, simply ask any clinician who makes their living actually treating
patients and billing insurance for their services. “Speed is key
and care processes are not well defined” as the default condition for the
current practice of medicine – it is in no way limited to the ICUs and ERs. 
A large amount of information on digital access is useful to care
coordinators who are salaried to manage a fairly small caseload of patients with
chronic conditions. The time constraints placed by the market on
the physician-patient encounter do not allow for the thoughtful assessment of
large quantities of historical data by a practicing physician. Physicians are happy with their CPOE/EMR system in the salaried and
subsidized world of the VA. Outside of that arena, the
administration and the 1-3 physician champions of EMR in each health care system
will be the primary sources of effusive positive regard for EMRs, but those of
us in the trenches are typically not quoted and not happy. Having
been forced to use these CPOE/EMR systems and seeing them severely limit the
efficiency and safety of medical care, as well as increasing error rates, I am
among the practicing physicians who can wax eloquent about their problems.

You are correct in the need for aggressive assessment of
the way medicine is practiced and huge investment in improving human-computer
interface systems in order for the EMRs to work well and realize any savings of
dollars or lives. However, I believe you are incorrect in
predicting that the stories you quote may result in stopping the movement toward
EMRs because it is “easier for hospitals and physician groups to do
nothing”. This is not true. The move toward EMRs is
not being led by physicians or hospitals, so our input is amazingly
irrelevant. The movement is largely based on a fallacy that
improved technology will lead to decreased cost, with a side bar of improved
quality of health care. It is led by business interests and
followed by the government – ie, the payors. Improved technology will be a huge
boon for consulting firms, administrators, and other types of technician and
advisors. It will absolutely not decrease costs. Only improved rationing of health care resources will do that. However, since no one wants to deal with the true issue, our current
resources have been diverted to The Holy Grail of Techno-Salvation. The interests behind this are well-entrenched and will not be stopped by
a few facts that contradict their ideology. This is evident with
the push to P4P, when there are almost no “performance” scales that are relevant
to medical care for real patients with real co-morbid
medical/social/psychological issues that impact their health and health
care.
It is not easier for hospitals to do nothing, because
Medicare continues to be a main player on their field, and the push toward
electronics by Medicare cannot be ignored by hospitals. As
economies of scale push toward large Kaiser-like systems and physicians move to
stable jobs being employed by large entities, EMRs will make more sense. In the meantime, the move toward these large systems of care, including
the fits and starts of competing EMRs, will lead to more wasted health care
dollars and worse medical care, as well as complaints by bitter physicians who
are being devolved from being professionals toward being marginalized purveyors
of a technical commodity.

I actually agree with much of what Kelly says especially about the lack of conversation about rationaing, although I’m not so sure that payors are leading the way towards EMRs, or that anyone is. I suspect that underlying the lack of appreciation of the EMR is the realization that it in fact only really makes sense for bigger organizations. What Kelly may be underestimating is the ability of the AMA and others to delay the imposition of IT, such as the rejection of the mandating of electronic prescribing in the House-Senate conference of Medicare Part D. But this debate and this process is by no means settled.

BLOGS/POLICY: And over at Spot-on, c’est moi

I have found myself another gig amongst a great group of political writers led by the intrepid Chris Nolan. Chris is a leading Silicon Valley journo and a policy wonk, and she has surrounded herself with a group of op-ed type writers whose politics are absolutely across the map, but whose writing is entertaining and incisive. She calls it “standalone journalism” and I’m happy to be along for the ride. The intention is that I do a weekly piece over there which will be a bit longer and more political than the health care wonkery you tend to see here. I hope you’ll all go over and take a look, not just at my pieces but at all of them.

The site is called Spot-on, and my first piece is called Adventures in a Health Care Nation.

PHARMA: Looks like more good news for the Vioxx plaintiff bar!

So according to the NEJM there were serious errors in the original Vioxx study–that is errors of omission.

The New England Journal of Medicine publicly alleged Thursday at least two of the authors of a major Canadian-led study on the former blockbuster drug Vioxx withheld data on adverse events from the journal.

So as the NEJM now says the Merck team hid an additional three heart attacks from the data in the VIGOR study as the deaths occurred after a cut-off date. If they’d included them the risk of having an MI was 500% higher not 425% higher with Vioxx compared to an NSAID.

On the other hand why didn’t the researchers just move the cut-off dates for deaths in Vioxx patients in study back to before they started on the drug. That would have produced much better data!

assetto corsa mods